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executive summary
Background
The Home Office estimates that drug related crime 
costs £13.9bn per year1 and that offenders who use 
heroin, cocaine or crack cocaine commit between 
a third and a half of all acquisitive crimes2. As a 
result, reducing drug-related crime is one of the 
main objectives of the government’s drug strategy3. 
This recognises that the provision of good quality 
drug treatment, combined with stable housing and 
employment, can be very effective in preventing high 
volume acquisitive offending. 
Drug addicted people often develop a tolerance 
through daily compulsive use, which can result in 
an expensive addiction. For instance, the estimated 
average value of drugs used in the four weeks prior to 
treatment among participants of the Drug Treatment 
Outcomes Research Study (DTORS) was £1,2964. With 
little income they may resort to crime to pay for their 
drug use. This might include acquisitive crimes such 
as shoplifting, burglary or robbery, or other financially 
motivated crimes such as soliciting and begging. Drug 
treatment is designed to reduce people’s need for 
drugs, which in turn reduces the driving force behind 
their drug-related offending.
The National Treatment Agency for Substance Misuse 
(NTA) has worked closely with economists in the 
Home Office (HO) and the Department of Health (DH)
to build a Value for Money (VFM) model in response 
to the National Audit Office recommendation to 
develop a framework for evaluating value for money 
in relation to the previous drug strategy5. The VFM 
model estimates the crime prevention and health 
improvement benefits of treatment and recovery. This 
is the first time such estimates have been made at a 
national level.
This report sets out a detailed explanation of how the 
estimates were calculated for the crime component 
of the VFM model and has been endorsed by HO. 
It will be followed by a publication later this year on 
the health improvement benefits of drug treatment, 
presenting our work with DH on the potential 
improvements to Quality Adjusted Life Years (QALYs) 
from drug treatment and recovery. Crime prevention 
and health improvement are not the only potential 
benefits of drug treatment. There are a variety of 
different harms associated with drug use and we hope 
to look at other potential benefits of treatment and 
recovery in relation to these in the future.
Findings
We estimate that drug treatment and recovery systems 
in England may have prevented approximately 4.9m 
crimes in 2010-11, with an estimated saving to 
society of £960m in costs to the public, businesses, 
the criminal justice system and National Health 
Service (NHS). We also estimate that approximately 
19.6m crimes may be prevented over the course of 
the Spending Review 2010 period (SR10) (2011-12 
to 2014-15), with an estimated saving to society of 
£3.6bn.
In addition we estimate that up to a further 4.1m 
offences may be prevented over a nine year period 
(from 2011-12 to 2019-2020), because we estimate 
that 13,702 people who left treatment in 2010-11 will 
go on to sustain long term recovery, with an estimated 
value of £700m. We also estimate that continued 
investment in drug treatment over the SR10 period 
could lead to up to an estimated 54,000 former clients 
sustaining long term recovery which may prevent up 
to 16.6m more offences with an estimated value of up 
to £2.6bn by 2023-24.
The model also helps us to estimate the potential 
impact of disinvestment in adult drug treatment. We 
estimate that, all else being equal, for every £1m 
taken out of the system there could be an increase of 
approximately 9,860 drug-related crimes per year at 
an estimated cost to society of over £1.8m. 
These findings are based on an empirical analysis of 
data from the National Drug Treatment Monitoring 
System (NDTMS) linked to conviction records from the 
Police National Computer (PNC) and on self reported 
offences data from DTORS.  
Qualifications
Many of the figures included in this report are 
estimates rather than observations and so these 
figures cannot be interpreted as direct, quantifiable 
measures of a causal effect of drug treatment and as 
such the findings are indicative and not definitive. We 
based our estimates on the best available evidence, 
but we are aware that there is not always as much 
evidence as we would like. These estimates can be 
improved over time as new evidence comes to light. 
Where evidence was not available we have had to rely 
on assumptions. 
4NTA 2012
1. introduction
There is a well established, but complex relationship 
between illicit drug use and crime6. This relationship 
differs between individuals and even for the same 
individual over time. For some, committing crime 
preceded drug use and for others drug use preceded 
criminality. Not everyone with a treatment need 
commits drug related crime, for instance roughly half 
of treatment clients do not7. Also some treatment 
clients will commit crime which is not drug related, this 
means that even if they stop taking drugs and recover 
from their addiction, they may continue to commit 
crime (Assumption 6, Appendix B).
The European Monitoring Centre for Drugs and 
Drug Addiction (EMCDDA) has identified four 
key explanations for drug related crime which 
highlight this complexity: economic-compulsive; 
psychopharmacological, systemic and drug law 
offences8. This report focuses on the first of these, the 
economic-compulsive relationship. 
The economic-compulsive relationship means that 
drug addicted people often develop a tolerance 
through daily compulsive use, which can result in 
an expensive addiction. For instance, the estimated 
average value of drugs used in the four weeks prior to 
treatment among participants of the Drug Treatment 
Outcomes Research Study (DTORS) was £1,2969. With 
little income they may resort to crime to pay for their 
drug use, such as shoplifting, burglary or robbery, or 
other crimes such as soliciting and begging. 
This report describes the evidence, assumptions and 
methodology which have been used to produce the 
crime component of the VFM model. We plan to 
publish a suite of themed papers on the Value for 
Money of drug treatment and recovery. This is the first 
of such papers and will be followed by a publication 
later this year on the health improvement benefits 
of drug treatment, presenting our work with the 
Department of Health on Quality Adjusted Life Years 
(QALYs). Crime prevention and health improvement 
are not the only potential benefits of drug treatment. 
There are a variety of different harms associated with 
drug use and we hope to look at other potential 
benefits of treatment and recovery in relation to these 
in the future. We have included a taxonomy of drug 
related harms in Appendix C.
Section 2 of this report estimates the counterfactual 
volume of drug related crime for clients in effective 
treatment. Section 3 estimates the counterfactual cost 
of drug related crime for clients in effective treatment. 
Section 4 estimates the potential reduction in drug-
related offending for clients who are in effective 
treatment. Section 5 estimates the potential impact of 
disinvestment in drug treatment. Section 6 estimates 
the potential reduction in drug-related offending for 
former clients who leave treatment successfully and 
are predicted to go on to sustain long term recovery. 
Appendix E includes data on the estimated number of 
former clients who go on to sustain long term recovery 
from their addiction.
These findings are based on an empirical analysis of 
data from the National Drug Treatment Monitoring 
System (NDTMS) linked to conviction records from the 
Police National Computer (PNC)10and on self reported 
offences data from the Drug Treatment Outcomes 
Research Study (DTORS). Appendix D includes a table 
which shows how we linked DTORS offence categories 
with offences in legislation.  A report detailing the 
NDTMS and PNC data matching results, The Impact of 
Treatment on Reconviction for Drug-Related Offences 
has recently been published to accompany this report. 
The VFM model only includes clients who have 
remained in treatment for at least 12 weeks (or exited 
prior to this in a care-planned way), which is the 
NDTMS measure of effective treatment. While there 
might be significant benefits for those individuals 
who do not reach the 12-week point or leave in an 
unplanned way before then, they have not been 
included in the analysis. Where we do provide 
estimates of potentially prevented offences at an 
individual level, the findings are for an average client 
and so we do not distinguish between opioid and/
or crack cocaine users (OCUs) and non-opioid and/or 
crack cocaine users (non-OCUs). We have provided a 
glossary of terms in Appendix A.
Many of the figures included in this report are 
estimates rather than observations and so these 
figures cannot be interpreted as direct, quantifiable 
measures of a causal effect of drug treatment and 
as such the findings are indicative and not definitive 
(Assumption 5, Appendix B). We have tried to base 
our estimates on the best available evidence, but we 
are aware that there is not always as much evidence as 
we would like. These estimates can be improved over 
time as new evidence comes to light. Where evidence 
was not available we have had to rely on assumptions. 
Appendix B provides a table of key assumptions.
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2. estimating the counterfactual 
volume of drug related crime for 
clients in effective treatment
To assess the impact of drug treatment on drug-related 
crime, we first needed to estimate what would have 
happened in the absence of treatment. This is known 
as the counterfactual. We have calculated an upper 
estimate, lower estimate and mid-point estimate.
2.1 Calculating the upper estimate 
Unfortunately, there is no data on the self-reported 
level of offending of drug users in the 12-month 
period prior to treatment, presumably because that 
length of recall is unlikely to be reliable or the study 
would be too costly and difficult. We therefore have to 
rely on estimates.
To do this, we used self-reported offence data from 
DTORS11. There were 1,796 drug users recruited to the 
study who were considered to be representative of the 
drug treatment population (Assumption 8, Appendix 
B). Of these, 1,698 participants were asked to report 
whether they had committed an offence in the 28-day 
period prior to being interviewed and if so the volume 
and type of offence that they had committed. A range 
of offences were reported, with the most common 
being shoplifting and the least common being house 
burglary. The mean number of self reported offences 
was 10.35 per person. As this report is focused on 
the economic-compulsive drug crime link, we have 
excluded ‘other violent crime’ from our analysis and 
so the average we use is 10.24 rather than the 10.35 
reported in DTORS (Table 1).
If the offences committed in the 28 days prior to 
treatment were representative of the year prior to 
treatment, then we could assume that each drug user 
commits 133.5 drug related offences on average each 
year when not in treatment (10.24*13.04). 
In 2010-11, there were 191,129 clients engaged in 
effective treatment. The NDTMS measure of treatment 
effectiveness refers to retaining clients in treatment for 
more than 12 weeks, or leaving the treatment system 
before then in a care-planned way. Only clients who 
meet these criteria are included in the VFM model.
If all of these clients were not in treatment, it is 
estimated that they would have committed a total of 
25.5m offences in the 12 months preceding treatment 
(133.5*191,129) (Table 2). We refer to this as the 
upper estimate in the VFM model.
2.2 Calculating the lower estimate
It could be argued that the four-week period prior to 
drug treatment is not representative of the year prior 
to treatment, because the offence pattern of drug 
T1. REpoRTEd oFFEnCEs in ThE FouR WEEks BEFoRE  
 TREaTmEnT (dToRs) 
DTORS offence type Mean number of offences
Shoplifting 3.71
Theft of a vehicle 0.05
Theft from a vehicle 0.15
House burglary 0.03
Business burglary 0.19
Violent theft (robbery) 0.06
Bag snatch 0.07
Cheque or credit card fraud 0.08
Begging 0.47
Buying and selling stolen goods 2.43
Drug dealing 2.13
Prostitution 0.49
Other stealing 0.38
Benefit Fraud No mean
Other violent crime 0.11
DTORS Total 10.35
Total (excluding violent crime) 10.24 (10.35 – 0.11)
T2. uppER EsTimaTE ToTal and pER pERson CounTERFaCTual oFFEnCEs By dToRs  
oFFEnCE CaTEgoRy 
DTORS offence type Estimated counterfactual offences 2010-11
Estimated average 
counterfactual offences 
per person 2010-11
Shoplifting 9,243,331 48.4
Theft of a vehicle 124,573 0.7
Theft from a vehicle 373,720 2.0
House burglary 74,744 0.4
Business burglary 473,378 2.5
Violent theft (robbery) 149,488 0.8
Bag snatch 174,402 0.9
Cheque or credit card fraud 199,317 1.0
Begging 1,170,988 6.1
Buying and selling stolen goods 6,054,257 31.7
Drug dealing 5,306,818 27.8
Prostitution 1,220,817 6.4
Other stealing 946,756 5.0
Total (excluding violent crime) 25,512,591 133
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using offenders can fluctuate, with peaks and troughs 
over the course of a year (and their drug taking 
‘career’ more generally) owing to a variety of complex 
and interconnected issues. 
Arguments could be made that the self-reported 
data is potentially an underestimate. For instance, 
in DTORS, respondents were asked whether their 
offending in the four weeks prior to interview was 
“More, less or the usual amount” and found that 
43% of the participants said that they had offended 
less than usual. In addition, 40% of treatment seekers 
reported to use a lesser quantity of drugs14. However, 
it is not possible to determine from the data what the 
true extent of this underestimate might have been and 
so for the purposes of the VFM model we have not 
increased the upper estimate. 
Conversely, it could also be argued that it is an 
escalation in drug use and therefore drug related 
offending which causes some individuals to come 
into contact with drug treatment either through self 
referral or criminal justice referral. Indeed, 24% of 
DTORS respondents reported to offend more than 
usual before starting treatment.
To address this issue we anonymously matched 
convictions data from the PNC with data from NDTMS 
for the cohort of 53,851 individuals starting treatment 
during the financial year 2006-07. This analysis 
enabled an observation of the conviction rates for 
‘trigger offences’15 in the year prior to treatment. It is 
important to note however, that convictions will not 
necessarily reflect the pattern of actual offending, 
however for the purpose of the VFM model we have 
assumed that they do (Assumption 7, Appendix B).
As Figure 1 shows, the greatest number of convictions 
occurs in the four weeks immediately before clients 
engage with treatment, suggesting that there could 
be increased criminal behaviour during that time. The 
graph is divided into thirteen 28-day periods to mirror 
the 28-day period used in DTORS. The upper line 
shows the level of convictions if the four-week period 
before treatment was representative and the lower 
line shows the mean conviction rate for the year. 
Assuming the convictions trend is a good proxy for 
offences, the findings support the argument that the 
four-week DTORS self-reported data is unrepresentative 
of the previous 12 months offending activity. 
However, a case could be made that the observed 
pattern is biased towards a greater rate of convictions 
in the four weeks before treatment due to the close 
working relationship between the criminal justice and 
drug treatment systems. There is a direct referral route 
0
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T3. ConviCTions in ThE 13x28-day pERiods BEFoRE dToRs inTERviEW 
Four-week period  
pre DTORS 
interview
Actual 
convictions
Proportion of 
convictions
Convictions if 
DTORS period was 
representative
Proportion if 
DTORS period was 
representative
13 2,429 6.6% 4,716 7.7%
12 2,382 6.5% 4,716 7.7%
11 2,352 6.4% 4,716 7.7%
10 2,401 6.5% 4,716 7.7%
9 2,371 6.4% 4,716 7.7%
8 2,396 6.5% 4,716 7.7%
7 2,435 6.6% 4,716 7.7%
6 2,608 7.1% 4,716 7.7%
5 2,675 7.3% 4,716 7.7%
4 2,937 8.0% 4,716 7.7%
3 3,162 8.6% 4,716 7.7%
2 3,932 10.7% 4,716 7.7%
1 4,716 12.8% 4,716 7.7%
Total 36,796 100% 61,303 100%
F1. RaTE oF ConviCTions in ThE yEaR pRioR To TREaTmEnT FoR 53,851 individuals 
sTaRTing TREaTmEnT in 2006-07
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for individuals into treatment following arrest for a 
drug-related offence: an appearance in the PNC data 
of a trigger offence means there is a greater probability 
the same individual would then appear in NDTMS data. 
This is supported by the convictions data itself which 
reveals that the mean convictions per offender in the 
two-year period prior to treatment was 1.30 compared 
to 1.35 in the 30-day period prior to treatment. What 
this data shows is that the increase in offences in the 
30-day period prior to treatment is primarily a property 
of the increasing number of offenders being convicted 
just prior to treatment, rather than the number of 
convictions per person increasing. 
A further complication is that DTORS did not always 
interview participants on the day that they engaged 
with treatment. In fact, the average time elapsed 
between the initial contact with the drug treatment 
service and the DTORS interview was 13 days. This 
means that on average, almost half of the 28 days 
within which each person was asked to recall their 
offending behaviour in the previous four weeks 
actually occurred after they had engaged with 
treatment, thereby potentially reducing the likelihood 
of offending or other harmful actions. To deal with 
this anomaly, we adjusted the 28-day window prior 
to a hypothetical DTORS interview date (i.e. to 
include convictions committed 13 days after starting 
a treatment intervention, as well as 15 days before) 
when modelling the annual rate of offending using 
the PNC data. This gives a figure of 4,716 offences 
occurring during the equivalent period of the DTORS 
interview (see period 1 in Table 3). Each other period in 
the table below represents a 28-day window counted 
back from this index period.  
If all convictions happened equally during the 
previous year, the assumption which the upper 
estimate is based on, then each 28-day period 
would provide 7.7% (28/365) of the convictions. 
However, the proportion of convictions occurring in 
the relevant period versus the annual total is 12.8% 
(4,716/36,796). 
Assuming that the number of convictions is 
proportionate to the volume of actual offences 
committed in a given period, a lower estimate of the 
annual cost of drug-related crime can be established 
by supposing that the criminal activity reported at 
the DTORS interview is taken to represent 12.8% 
of crimes committed during the whole year. This 
lower estimate of the annual number of drug-
related offences is thus 60% of the upper estimate 
(36,796/61,308) (Table 4). 
T4. loWER EsTimaTE ToTal and pER pERson CounTERFaCTual oFFEnCEs By dToRs  
oFFEnCE CaTEgoRy 
DTORS offence type Estimated counterfactual offences 2010-11
Estimated average 
counterfactual offences 
per person 2010-11
Shoplifting 5,547,687 29.0
Theft of a vehicle 74,767 0.4
Theft from a vehicle 224,300 1.2
House burglary 44,860 0.2
Business burglary 284,113 1.5
Violent theft (robbery) 89,720 0.5
Bag snatch 104,673 0.5
Cheque or credit card fraud 119,627 0.6
Begging 702,807 3.7
Buying and selling stolen goods 3,633,660 19.0
Drug dealing 3,185,060 16.7
Prostitution 732,713 3.8
Other stealing 568,227 3.0
Total (excluding violent crime) 15,312,215 80
T5. mid-poinT EsTimaTE ToTal and pER pERson CounTERFaCTual oFFEnCEs By  
dToRs oFFEnCE CaTEgoRy 
DTORS offence type Estimated counterfactual offences 2010-11
Estimated average 
counterfactual offences 
per person 2010-11
Shoplifting 7,395,509 38.7
Theft of a vehicle 99,670 0.5
Theft from a vehicle 299,010 1.6
House burglary 59,802 0.3
Business burglary 378,746 2.0
Violent theft (robbery) 119,604 0.6
Bag snatch 139,538 0.7
Cheque or credit card fraud 159,472 0.8
Begging 936,897 4.9
Buying and selling stolen goods 4,843,959 25.3
Drug dealing 4,245,939 22.2
Prostitution 976,765 5.1
Other stealing 757,492 4.0
Total (excluding violent crime) 20,412,403 107
T6. EsTimaTEs oF ThE uppER, mid-poinT and loWER EsTimaTEs oF ThE volumE oF  
CounTERFaCTual oFFEnCEs FoR CliEnTs in EFFECTivE TREaTmEnT 2010-11 
Estimated 
counterfactual  
crimes 2010-11 (per 
person)
Number of clients in 
effective treatment
Estimated 
counterfactual  crimes 
2010-11
Upper estimate 133 191,129 25.5m
Mid-point estimate 107 191,129 20.4m
Lower estimate 80 191,129 15.3m
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2.3 Calculating the mid-point estimate
As there is not an overwhelming argument either 
way between using the lower or upper estimates, we 
decided to use the mid-point between them as our 
estimate of the counterfactual of drug-related crimes, 
or in other words the number of drug-related crimes 
which might have been committed if no drug users 
were in effective treatment in 2010-11 (Table 5). 
The mid-point estimate is 20.4m and is the mean of 
the upper and lower estimates. This translates into 
107 offences per person per year on average. As this is 
an average it is worth remembering that some clients 
will have committed no offences at all and others will 
have committed more than this.
Throughout the report we provide estimates based on 
the mid-point, but also a range using the upper and 
lower estimates. Table 6 provides a summary of the 
three estimates. 
3. estimating the counterfactual cost 
of drug related crime for clients in 
effective treatment
The Home Office (HO) has estimated the economic 
and social costs of crime against individuals and 
households. However, they have not estimated all of 
the crimes which are included in the DTORS offence 
categories. This means that our cost estimates will 
underestimate the counterfactual cost of drug related 
crime. Table 7 highlights which DTORS offence 
categories we have been able to cost and those we 
have excluded and why.
Table 8 sets out the unit costs we have used in the 
VFM model based on the most up to date estimates 
provided by the HO.18 The HO was content for ‘Theft – 
not vehicle’ to be used as a proxy for ‘bag snatch’ and 
‘cheque or credit card fraud’. The unit costs of drug-
related offences are made up of a range of elements 
that are incurred by different groups, such as the 
physical and emotional impact on victims and costs to 
individuals, businesses and public services19. 
These unit costs can then be multiplied by the 
estimated annual offences to estimate the 
counterfactual costs of offending in 2010-11. The 
mid-point estimate is £5bn with a range from £3.7bn 
to £6.2bn (Table 9). Note that these figures cannot 
be directly compared to the estimated social and 
economic cost of drug related crime in the HO Online 
Report 16/06. The latter’s estimate of £13.9bn was 
based on National Treatment Outcomes Research 
Study (1998) offending data whereas the approach 
described in this paper is based on data from the more 
recent DTORS (2007). They also both use a different 
subset of crime types and the latter estimate was not 
T7. dToRs oFFEnCEs ExCludEd FRom ouR CosT EsTimaTEs 
DTORS offence type Costs included Reason for exclusion
Shoplifting yes
Theft of a vehicle yes
Theft from a vehicle yes
House burglary yes
Business burglary yes
Violent theft (robbery) yes
Bag snatch yes
Cheque or credit card fraud yes
Buying and selling stolen 
goods no
In calculating the unit cost of buying and 
selling stolen goods, the costs to the victim of 
the original theft have already been counted 
within other categories and the criminal 
justice system costs have not been calculated 
by the Home Office. It was also omitted from 
the estimated costs of drug-related crime in 
DTORS for these reasons.
Begging no
The Home Office has not estimated the costs 
of these offences as its estimates are generally 
of crimes against individuals and households 
and begging, drug dealing and prostitution are 
classed as neither. They were also omitted 
from the estimated costs of drug-related 
crime in DTORS for this reason.
Drug dealing no
Prostitution no
Other stealing no
There is no unit cost for this offence as it is not 
a statutory offence, but rather a term used in 
the DTORS questionnaire on offending.  
T8. uniT CosT oF oFFEnCEs inCludEd in ThE vFm modEl 
DTORS offence type Unit cost 2010-11 prices
Shoplifting £124
Theft of a vehicle £4,970
Theft from a vehicle £1,034
House burglary £3,925
Business burglary £4,608
Violent theft (robbery, personal) £8,810
Bag snatch (theft, not vehicle) £763
Cheque/credit card fraud (theft, not vehicle) £763
T9. EsTimaTEs oF ThE ToTal CounTERFaCTual CosT oF oFFEnding in 2010-11 
(2010-11 pRiCEs) 
DTORS offence type Lower estimate Mid-point estimate Upper estimate
Shoplifting £688m £917m £1,146m
Theft of a vehicle £372m £495m £619m
Theft from a vehicle £232m £309m £386m
House burglary £176m £235m £293m
Business burglary £1,309m £1,745m £2,181m
Violent theft (robbery) £790m £1,054m £1,317m
Bag snatch £80m £106m £133m
Cheque or credit card fraud £91m £122m £152m
Begging Unknown Unknown Unknown
Buying and selling stolen goods Unknown Unknown Unknown
Drug dealing Unknown Unknown Unknown
Prostitution Unknown Unknown Unknown
Other stealing Unknown Unknown Unknown
Total £3.7bn £5bn £6.2bn
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a counterfactual. Also this paper only estimates the 
counterfactual for clients in effective treatment and 
does not estimate the drug related crime cost for 
clients who are not in effective treatment.
These estimates can then be divided by the number 
of clients in effective treatment to estimate the 
counterfactual costs of offending per person in 2010-
11. The estimated cost per person using the mid-
point estimate is £26,074 with an estimated range of 
£19,559 to £32,589 (Table 10).
4. estimating the potential reduction 
in drug-related offending for clients 
in effective treatment
The NTA study ‘The Impact of Drug Treatment on 
Reconviction’21 compared the differences in the 
conviction rates of known offenders in the two years 
before their initial assessment for drug treatment 
and the two years after. It presented the results of an 
analysis of data from NDTMS and conviction records 
from the PNC using the government’s Drug Data 
Warehouse (DDW)22. 
The data is drawn from a cohort of people who started 
a new course of drug treatment in 2006-07 and who 
had at least one conviction during the two years prior 
to their start date. The study was limited to trigger 
offences and sex working. It found that the individuals 
retained in treatment for the entire two-years (4,677) 
showed an average 47% reduction in convictions. 
The VFM model is also based on the data contained 
in the DDW, but a slightly different method has been 
used which is why the results differ. While the report 
described above focused on people with a previous 
conviction, the VFM model focuses on all clients, 
whether they had a conviction or not prior to starting 
treatment. It also only includes people who were in 
treatment continuously for two years from when they 
started treatment in 2006-07, whereas the previous 
report only specified that people had to have started 
treatment in 2006-07. 
Two years of continuous treatment contact have been 
used to represent as closely as possible the average 
length of time a client spends in continuous treatment 
and also because the purpose of this analysis was to 
best estimate the protective factor treatment has on 
reducing offending during the time that clients are 
engaged in effective treatment. There were 13,819 
individuals included in this category.
By anonymously matching the cohort of 13,819 
individuals on NDTMS with PNC data, for two years 
before and two years after they started treatment in 
2006-07, it was possible to determine the change in 
T10. EsTimaTEs oF ThE ToTal CounTERFaCTual CosT oF oFFEnding pER pERson in 
2010-11 (2010-11 pRiCEs) 
DTORS offence type Lower estimate Mid-point estimate Upper estimate
Shoplifting £3,599 £4,798 £5,997
Theft of a vehicle £1,944 £2,592 £3,239
Theft from a vehicle £1,213 £1,618 £2,022
House burglary £921 £1,228 £1,535
Business burglary £6,850 £9,131 £11,413
Violent theft (robbery) £4,136 £5,513 £6,891
Bag snatch £418 £557 £696
Cheque or credit card fraud £478 £637 £796
Begging Unknown Unknown Unknown
Buying and selling stolen goods Unknown Unknown Unknown
Drug dealing Unknown Unknown Unknown
Prostitution Unknown Unknown Unknown
Other stealing Unknown Unknown Unknown
Total £19,559 £26,074 £32,589
T11. ThE REduCTion in ConviCTions BEFoRE and duRing TREaTmEnT FoR ThE 
sTudiEd CohoRT 
DTORS offence type
Convictions 
in the two 
years before 
treatment, less 
those from one 
month before 
Convictions 
in the two 
years after 
treatment, less 
those from one 
month after 
Percentage 
change Reduction
Shoplifting 7,247 5,763 -20% -1,484
Theft of a vehicle 315 230 -27% -85
Theft from a vehicle 349 260 -26% -89
House burglary 527 320 -39% -207
Business burglary 521 426 -18% -95
Violent theft (robbery) 100 60 -40% -40
Bag snatch 175 132 -25% -43
Cheque or credit card fraud 686 327 -52% -359
Begging 247 181 -27% -66
Buying/selling stolen goods 511 278 -46% -233
Drug dealing 602 354 -41% -248
Prostitution 221 111 -50% -110
Other stealing 1,222 930 -24% -292
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rates of convictions pre- and post- starting treatment. 
The VFM model assumes that the change in 
convictions is representative of the change we would 
see in offences and that this relationship remains the 
same after conviction (Assumption 7, Appendix B). 
To be able to estimate the change in offending in 
the VFM model notifiable offences in the PNC were 
matched to DTORS offence categories. A table 
showing which DTORS offence categories were 
matched to offences in legislation has been included 
in Appendix D.
To remove the potential systemic bias mentioned in 
section 3 of this report, where convictions increase 
prior to treatment, convictions from the 30 days prior 
to treatment start were removed in line with Home 
Office ‘index offence’ methodology23. 
There are different rates of reduction for different 
offences (Table 11). The three greatest percentage 
reductions in convictions were in cheque or credit 
card fraud, prostitution and buying and selling stolen 
goods (-52%, -50% and -46% respectively). The 
greatest reduction in the volume of convictions was in 
shoplifting (-1,484).
The VFM model only includes clients who have 
remained in treatment for at least 12 weeks (or exited 
prior to this in a care planned way) which is the 
NDTMS measure of effective treatment. While there 
might be significant benefits for those individuals 
that do not reach the 12-week point or leave in an 
unplanned way before then, they have not been 
included in the analysis (Assumption 9a, Appendix B).
The percentage changes in convictions from Table 11 
were then applied to the counterfactual offences set 
out in Tables 2, 4 and 5 and adjusted to reflect the 
mean time that effective treatment clients spent in 
treatment in 2010-11, which is 73% of the year as, 
as we did not want to claim benefits when individuals 
were not in treatment. 
For example, the mid-point estimate of the 
counterfactual number of shoplifting offences in 
2010-11 was 7,395,625 (Table 5). This was multiplied 
by the 20% reduction calculated in Table 10 and then 
adjusted for the mean time in effective treatment 
(7,395,625*0.20*0.73) which comes to 1,101,148 
shoplifting offences which may have been prevented 
by drug treatment in 2010-11 (Table 12).
We estimate that drug treatment may have prevented 
4.9m offences in 2010-11, with a range from 3.7m 
to 6.1m (Table 12). This translates into an estimate 
that treatment may have prevented on average of 26 
T12. EsTimaTEd REduCTion in ToTal oFFEnCEs 2010-11 
DTORS offence type Lower estimate Mid-point estimate Upper estimate
Shoplifting 826,018 1,101,148 1,376,277
Theft of a vehicle 14,670 19,556 24,442
Theft from a vehicle 41,591 55,444 69,297
House burglary 12,812 17,080 21,347
Business burglary 37,669 50,215 62,762
Violent theft (robbery) 26,095 34,786 43,478
Bag snatch 18,701 24,930 31,159
Cheque or credit card fraud 45,520 60,681 75,843
Begging 136,548 182,029 227,510
Buying and selling stolen goods 1,204,706 1,605,969 2,007,233
Drug dealing 954,058 1,271,835 1,589,612
Prostitution 265,177 353,502 441,828
Other stealing 98,727 131,611 164,495
Total 3,682,290 4,908,786 6,135,282
T13. EsTimaTEd REduCTion in oFFEnCEs pER pERson on avERagE 2010-11 
DTORS offence type Lower estimate Mid-point estimate Upper estimate
Shoplifting 4.32 5.76 7.92
Theft of a vehicle 0.08 0.10 0.13
Theft from a vehicle 0.22 0.29 0.36
House burglary 0.07 0.09 0.11
Business burglary 0.20 0.26 0.33
Violent theft (robbery) 0.14 0.18 0.23
Bag snatch 0.10 0.13 0.16
Cheque or credit card fraud 0.24 0.32 0.40
Begging 0.71 0.95 1.19
Buying and selling stolen goods 6.30 8.40 10.50
Drug dealing 4.99 6.65 8.32
Prostitution 1.39 1.85 2.31
Other stealing 0.52 0.69 0.86
Total 19 26 33
T14. EsTimaTEd REduCTion in ToTal oFFEnCEs (sR10) using ThE mid-poinT 
DTORS offence type
Spending Review 2010
2011-12 2012-13 2013-14 2014-15
Shoplifting 1,101,148 1,101,148 1,101,148 1,101,148
Theft of a vehicle 19,556 19,556 19,556 19,556
Theft from a vehicle 55,444 55,444 55,444 55,444
House burglary 17,080 17,080 17,080 17,080
Business burglary 50,215 50,215 50,215 50,215
Violent theft (robbery) 34,786 34,786 34,786 34,786
Bag snatch 24,930 24,930 24,930 24,930
Cheque or credit card fraud 60,681 60,681 60,681 60,681
Begging 182,029 182,029 182,029 182,029
Buying/selling stolen goods 1,605,969 1,605,969 1,605,969 1,605,969
Drug dealing 1,271,835 1,271,835 1,271,835 1,271,835
Prostitution 353,502 353,502 353,502 353,502
Other stealing 131,611 131,611 131,611 131,611
Total 4,908,786 4,908,786 4,908,786 4,908,786
SR10 Total 19,635,146
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offences per client in effective treatment in 2010-
11(with a range from 19 to 33 offences) (Table 13). 
Assuming that the same number of people will 
be treated in each of the four years of the SR10 
period (2011-12 to 2014-15) and that all the other 
factors hold constant, such as mean time in effective 
treatment and the crime prevention rate, we estimate 
that 19.6 million offences may be prevented over the 
SR10 period (Table 14), with a range from 14.7m m to 
24.5m (Assumptions 10-13, Appendix B).
Unit costs, where available, can be applied to the 
estimated number of offences which have may have 
been prevented. We were not able to cost 72% of 
the total number of offences and so we will have 
underestimated the value of the offences which may 
have been prevented. We estimate that the total 
benefit was £961m in 2010-11 ranging from £721m 
to £1,201m (Table 15).
These estimates can be divided by the number of 
clients in effective treatment to estimate the potential 
benefit per person, which is £5,030 on average in 
2010-11 using the mid-point, with a range from 
£3,773 to £6,376 (Table 16). 
We estimate that, all else being equal, the value of the 
total offences which may be prevented by treatment 
over the spending review period will be £3.6bn (Table 
17), with a range of £2.7bn to £4.5bn. The benefits 
reduce each year because they have been discounted. 
For an explanation about discounting refer to the 
discounting definition in the glossary (Appendix A). 
We have split the benefits in 2010-11 into cost savings 
(80%) and natural benefits (20%). Cost savings and 
natural benefits are terms used by DH. HO refers 
to cost savings as cashable benefits and natural 
benefits as non-cashable benefits. Cost savings are 
reductions to the costs to individuals, businesses and 
public services brought about by the investment in 
treatment. Natural benefits measure the reduction in 
the physical and emotional impact on direct victims 
of crime and they are encapsulated by DH and HO in 
a measurement known as ‘quality adjusted life years’ 
(QALYs). In line with HO unit costs, all of the offences 
in the VFM model are assumed to have a physical and 
emotional impact on victims except for shoplifting and 
business burglary.
Cost savings can be disaggregated into savings to 
individuals and businesses (50%), savings to the 
criminal justice system and victim services (28%), 
and savings to the NHS (2%) (Figure 2). The NHS 
cost savings relate to the reduced physical harm 
perpetrated on victims due to fewer robberies.
T15. EsTimaTEd valuE oF ThE REduCTion in ToTal oFFEnCEs 2010-11 pRiCEs 
DTORS offence type Lower estimate Mid-point estimate Upper estimate
Shoplifting £102.4m £136.5m £170.7m
Theft of a vehicle £72.9m £97.2m £121.5m
Theft from a vehicle £43.0m £57.3m £71.7m
House burglary £50.3m £67.0m £83.8m
Business burglary £173.6m £231.4m £289.2m
Violent theft (robbery) £230.0m £306.5m £383.0m
Bag snatch £14.3m £19.0m £23.8m
Cheque or credit card fraud £34.7m £46.3m £57.9m
Total £721m £961m £1,201m
T16. EsTimaTEd valuE oF ThE REduCTion in oFFEnCEs pER pERson on avERagE 
2010-11 pRiCEs 
DTORS offence type Lower estimate Mid-point estimate Upper estimate
Shoplifting £536 £714 £983
Theft of a vehicle £381 £509 £636
Theft from a vehicle £225 £300 £375
House burglary £263 £351 £438
Business burglary £908 £1,211 £1,513
Violent theft (robbery) £1,203 £1,603 £2,004
Bag snatch £75 £100 £124
Cheque or credit card fraud £182 £242 £303
Total £3,773 £5,030 £6,376
T17. EsTimaTEd valuE oF ThE REduCTion in ToTal oFFEnCEs (sR10) using ThE mid-
poinT EsTimaTE (2010-11 pRiCEs) 
DTORS offence type
Spending Review 2010
2011-12 2012-13 2013-14 2014-15
Shoplifting £131.9m £127.5m £123.2m £119.0m
Theft of a vehicle £94.3m £91.4m £88.7m £86.0m
Theft from a vehicle £55.7m £54.2m £52.7m £51.2m
House burglary £65.0m £63.1m £61.2m £59.4m
Business burglary £223.6m £216.0m £208.7m £201.6m
Violent theft (robbery) £298.5m £290.9m £283.4m £276.1m
Bag snatch £18.4m £17.9m £17.3m £16.8m
Cheque or credit card fraud £44.9m £43.5m £42.2m £41.0m
Total £932.4m £904.4m £877.4m £851.2m
SR10 Total £3.6bn
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5. estimating the potential impact of 
disinvestment in drug treatment
We have calculated that for every £1m disinvested in 
treatment there would be an increase of 9,800 crimes 
per year at an additional cost of over £1.8m. This 
scenario is based on the mid-point estimate and the 
assumptions listed in Appendix B. An example of a 
reduction of £1m in 2012-13 is provided below.
The budget for community drug treatment in 2012-13 
is estimated to be £597.3m. For purposes of the VFM 
model we have only estimated the potential benefits 
from the estimated £497.7m spend on structured 
drug treatment for adults and have not estimated 
the benefits nor included the costs from unstructured 
treatment. 
Assuming that the same number of clients will be 
engaged in effective treated in 2012-13 as in 2010-
11 then the unit cost per person engaged in effective 
treatment will be £2,604 (£497.7m/191,129). So 
if £1m was taken out of the treatment system an 
estimated 384 fewer people would be engaged in 
effective treatment (£1m/£2,604) (Table 18). 
Assuming that the estimated crime prevention rate 
from treatment remains the same, with 384 fewer 
clients in effective treatment we estimate that there 
would be an additional 9,863 offences committed 
each year and the increased cost of the offences we 
have been able to ascribe a value to would be £1.8m 
(Table 19). It is important to bear in mind that this is 
one possible scenario rather than an evaluated result 
and that we have assumed that the calculated effect 
is an average applicable to even a large change in 
investment. There are arguments that might expect 
the effect to diminish the greater the change.
With fewer clients in effective treatment there would 
also potentially be a knock on effect to the number 
of people successfully completing and going on to 
sustain long term recovery in future years, but this has 
not been modelled. 
This scenario assumes that the disinvestment would 
fall equally across all treatment types. The number 
of people in effective treatment is the driver of cost 
savings. If the cuts fell heaviest on the most cost 
effective services, this would have a proportionately 
heavier impact on crime. Similarly, if the budget 
stays the same but is shifted towards more expensive 
modalities, this would imply a reduction in the 
numbers in treatment and an increase in crime 
(Assumption 14, Appendix B).
T18. EsTimaTEd REduCTion in numBERs in EFFECTivE 
TREaTmEnT pER £1m disinvEsTEd in 2012-13 (2012-13 pRiCEs)
Estimated number in effective treatment 191,129
Estimated treatment expenditure (cash terms) £497.7m
Unit cost per effective treatment client (annual) £2,604
Estimated reduction of number in effective treament 384
T19. ThE EsTimaTEd inCREasE in ThE CosT oF CRimE FoR EvERy £1m disinvEsTEd in 
TREaTmEnT 
DTORS offence type Increased crimes Increased cost of crime
Shoplifting 2,213 £256,113
Theft of a vehicle 39 £183,706
Theft from a vehicle 111 £108,858
House burglary 34 £126,731
Business burglary 101 £434,022
Violent theft (robbery) 70 £584,415
Bag snatch 50 £35,943
Cheque or credit card fraud 122 £87,488
Begging 366  No cost data
Buying and selling stolen goods 3,227  No cost data
Drug dealing 2,555  No cost data
Prostitution 710  No cost data
Other stealing 264  No cost data
Total (excluding violent crime) 9,863 £1,817,277
Natural 
benefits
£190.2m
Cost savings, 
individuals &
businesses
£480.9m Cost savings, 
Criminal Justice 
System & victim 
services 
£269.8m
Cost savings, 
NHS
£20.3m
F2. aTTRiBuTion oF EsTimaTEd CRimE pREvEnTion BEnEFiTs (2010-11)
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COUNTERFACTUAL DRUG-TAKING CAREER (AVERAGE 20 YEARS)
No benefit
In effective 
treatment 
benefit
Sustaining 
recovery 
benefit
Eight years to treatment Three years in treatment Career reduced by nine years
NDTMS indicates 
that on average 
an individual 
enters treatment 
eight years into 
his/her drug-
taking career
NDTMS data 
shows that 
clients remain 
in effective 
treatment for an 
average of three 
years
So clients 
sustaining their 
recovery are 
ascribed nine 
years’ worth of 
benefits
6. estimating the potential reduction 
in drug-related offending for former 
clients who go on to sustain long term 
recovery
In addition to estimating the potential benefits of 
clients being in effective treatment, the VFM model 
also estimates the potential benefits for clients who 
leave and go on to sustain long term recovery from 
their addiction. This is a new piece of analysis which 
has not been attempted before in previous drug 
treatment cost-benefit work.
It is reasonably straightforward to report how many 
individuals leave treatment successfully each year as 
this is collected by NDTMS, but because of the chronic 
relapsing nature of drug addiction, it is not so easy to 
determine how many former clients would then go 
on to sustain long term recovery. It is harder still to 
determine whether treatment hastens this process and 
if so by what degree. There is very little research on 
recovery, with imprecise and inconsistent definitions 
across studies and significant uncertainty about the 
length of time users are dependent on drugs. 
There are four elements that needed to be determined 
in order to estimate the potential benefits associated 
with former clients who sustain long term recovery. 
They are:
 •Estimating the period of time by which treatment  
 may hasten the recovery process 
 •Estimating the number of people who go on to  
 sustain long term recovery 
 •How to allocate the potential crime reduction  
 benefits of recovery over time
 •Estimating and valuing the potential crime reduction  
  of recovery.
Each of these elements will be explained in turn.
6.1 Estimating the period of time by which 
treatment may hasten the recovery process
The available literature supported by expert opinion 
suggests the average drug taking ‘career’ of heroin 
users is 20 years25 26 (Assumption 1, Appendix B). In 
the absence of any evidence to the contrary we have 
assumed this is the average counterfactual ‘career’ 
length for all drug users who have a treatment need. 
NDTMS data shows the median time from the start of 
a drug taking ‘career’ to the first treatment episode is 
eight years.27 NDTMS data also shows that for clients 
who leave successfully, their treatment journeys span a 
median period of three years28. So it could be assumed 
that clients’ drug taking ‘career’ has been reduced by 
nine years (20 years minus 3 + 8). Therefore, benefits 
for those assumed to be sustaining recovery could be 
allocated up to nine years from exit (Figure 3). 
F3. ThE CounTERFaCTual dRug Taking CaREER
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The 20-year counterfactual drug taking ‘career’ is an 
average and could range considerably from under 
one year to many decades. Furthermore, it could be 
argued that clients who we assume to be sustaining 
recovery in the model had a lower counterfactual drug 
taking ‘career’ than those who do not recover. For 
example, if the average counterfactual drug taking 
‘career’ was 19 years for those clients who sustain 
recovery, then it would only be appropriate to apply 
potential sustaining recovery benefits for 8 years rather 
than 9; if the counterfactual drug taking ‘career’ for 
those who go on to sustain long term recovery was 
18 years, then it would only be appropriate to apply 
potential sustaining recovery benefits for seven years 
rather than eight, and so on (Table 20). Hence, we 
have provided a range of estimates between 0-9 years’ 
worth of sustaining recovery benefits. 
6.2 Estimating the number of people who go on to 
sustain long term recovery 
As there are approximately 54,000 adults who leave 
structured treatment each year, it would not be 
practical or affordable to monitor their individual 
progress. However, it is possible to use the NDTMS and 
other databases that collect information about this 
client group to model how many do go on to lead lives 
free from drug dependency.
A Long-Term Study of the Outcomes of Drug Users 
Leaving Treatment selected the cohort of individuals 
that left drug treatment in 2005-06 and then used 
the NDTMS, the Drugs Intervention Record (DIR) in 
both prison and the community and Mandatory Drug 
Testing Data (MDT)29 to see if they re-presented to 
any of these datasets in the following four years30. 
While it is possible that some of those identified as 
not re-presenting may have had another drug-related 
event which was not picked up in these data sets, 
such as an admission to a hospital, the established 
link between drug use and crime supports the use 
of the three datasets analysed in the study as the 
most common that a client will appear in if they had 
relapsed after leaving treatment. The study found a 
steep reduction in the numbers of clients re-presenting 
year-on-year (roughly halving for each additional year 
following discharge from treatment). 
Building on this work a post hoc statistical analysis 
for the VFM model modelled future re-presentations 
based on the known trends of the observed data. This 
indicated that all clients who would ever re-establish 
contact with drug treatment or criminal justice 
agencies do so within ten years. This is consistent with 
previous studies, which suggest that beyond ten years 
the rate of relapse for opiate users, for example, is 
negligible31 32 (Assumption 3, Appendix B). 
YEAR 1 YEAR 2 YEAR 3 YEAR 4
Cohort in  
effective 
treatment
Cohort in  
effective 
treatment
Cohort in  
effective 
treatment
Cohort in  
effective 
treatment
Sustaining 
recovery flow 
year 1
Sustaining 
recovery flow 
year 2
Sustaining 
recovery flow 
year 3
Sustaining 
recovery flow 
year 4
Sustaining 
recovery cohort 
year 1
Sustaining 
recovery cohort 
years 1+2
Sustaining 
recovery cohort 
years 1+2+3
F4. modElling ThE susTaining RECovERy CohoRT ovER TimE
T20. CounTERFaCTual dRug-Taking CaREER lEngTh 
TRanslaTEd inTo ThE numBER oF yEaRs By WhiCh 
RECovERy is BRoughT FoRWaRd
Counterfactual length of drug 
taking ‘career’
Number of years of recovery 
may have been brought forward
20 years 9 years
19 years 8 years
18 years 7 years
17 years 6 years
16 years 5 years
15 years 4 years
14 years 3 years
13 years 2 years
12 years 1 year
11 years 0 years
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Figure 4 presents the estimated sustaining recovery 
rate over a ten-year period. We estimate that 51% 
of people who left successfully will be recorded on 
one of the data sets again over a ten-year period, 
which means that 49% of people are assumed to be 
sustaining long term recovery in the VFM model. So of 
the 53,952 people who exited treatment in 2010-11, 
27,969 of them left successfully and of these 13,702 
(49%) are estimated to go on to sustain long term 
recovery.
It is also possible that some people die and so for 
every year of the model post-treatment exit a 0.503% 
mortality rate is applied. This is the mortality rate for 
clients in effective treatment, which is used as a proxy 
for those people who are sustaining long term recovery 
(Assumption 15, Appendix B). This was calculated by 
dividing the number of deaths for clients in effective 
treatment in 2009-10 by the number of people in 
effective treatment in 2009-10 (967/192,360). 
Only clients who had been engaged in effective 
treatment before they left treatment successfully 
and did not re-present to either treatment or the 
criminal justice system are deemed to be sustaining 
long term recovery. Although there may be benefits 
from treatment for clients sustaining recovery who 
left treatment but were not engaged in effective 
treatment and also for clients who were engaged in 
effective treatment, but did not leave successfully, it 
is not possible to calculate how much of the benefit 
may have been treatment related, nor how long the 
benefit accrued and so these benefits have been 
excluded from the model (Assumption 4, Appendix 
B). Therefore the sustaining recovery benefits of drug 
treatment may have been underestimated as a result 
(Assumptions 9a. and 9b., Appendix B).
6.3 allocating the crime reduction benefits of 
recovery over time
Before the estimates of the potential crime reduction 
benefits of recovery can be presented it is first 
necessary to demonstrate how the benefits are 
allocated over time in the VFM model.
Taking Year 1 in Figure 4 as an example, a cohort of 
clients is engaged in effective treatment. Of this group, 
some would leave treatment and go on to sustain 
long term recovery. We refer to this cohort as the 
sustaining recovery flow year 1. No sustaining recovery 
benefits are allocated to the sustaining recovery flow 
year 1 as effective treatment benefits have already 
been attributed to them in that year and we did not 
want to double count. 
The sustaining recovery flow from Year 1 becomes the 
sustaining recovery cohort in Year 2. We then adjust 
T23. EsTimaTEd pERCEnTagE REduCTion in ConviCTions 
FoR pEoplE susTaining long-TERm RECovERy 
DTORS offence type Estimated reduction in convictions
Shoplifting 20%
Theft of a vehicle 26%
Theft from a vehicle 25%
House burglary 38%
Business burglary 18%
Violent theft (robbery) 39%
Bag snatch 24%
Cheque or credit card fraud 51%
Begging 26%
Buying and selling stolen goods 45%
Drug dealing 40%
Prostitution 49%
Other stealing 23%
Total 25.7%
T21. modElling ThE susTaining RECovERy CohoRT FRom 2010-11 ovER FouR yEaRs 
as an ExamplE 
Year 1 Year 2 Year 3 Year 4
2010-11 2011-12 2012-13 2013-14
Cohort in effective treatment 191,126 0 0 0
Sustaining recovery flow 13,702 0 0 0
Sustaining recovery stock 0 13,702 13,633 13,565
Sustaining recovery stock deaths 0 69 69 68
Sustaining recovery stock (mortality adjusted) 0 13,633 13,565 13,496
T22. mEan ConviCTions in ThE EighT yEaRs pRioR To TREaTmEnT jouRnEy sTaRT 
BRokEn doWn By RE-pREsEnTaTions and non RE-pREsEnTaTions
Non  
re-presentations Re-presentations All
Number of clients 21,039 30,461 51,500
Convictions in the eight years prior to 
leaving treatment 25,880 220,512 246,391
Mean convictions per person in the 
eight years prior to leaving treatment 1.23 7.24 4.78
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the number of people in the cohort using the mortality 
rate. Sustaining recovery benefits are only applied 
to clients in the sustaining recovery cohort. So for 
example in Year 2, benefits are applied to the clients in 
effective treatment in Year 2 and the sustaining cohort 
Year 1, but not the sustaining recovery flow Year 
2. This process continues with the cohort of clients 
sustaining recovery growing each year (in scenarios 
where there are more than 1 sustaining recovery year). 
Table 21 shows this process over a four-year period 
as an example. Full tables showing the sustaining 
recovery cohorts for the different scenarios are 
included in Appendix E.
6.4 Estimating and valuing the potential crime 
reduction benefits of recovery 
Finally we estimated and attached a value to the crime 
reduction benefits of recovery. 
Because by definition, people who are sustaining 
recovery are not committing drug related crime one 
method would be to assume that the crime prevention 
benefit for these people each year is equal to the crime 
counterfactual mid-point estimate of £26,074, for each 
year that their recovery has been brought forward.
However, it could be argued that this might 
overestimate the benefits of recovery if the more 
entrenched and chaotic clients who are committing 
more offences are less likely to sustain their recovery 
after leaving treatment than the less prolific offenders 
or those who are not committing offences at all.
To test this assumption a bespoke piece of analysis 
was commissioned from the Home Office Drug Data 
Warehouse (DDW) and carried out by the National 
Drug Evidence Centre (NDEC) at the University of 
Manchester.  
Clients who left treatment in 2005-06 were followed 
over three years, the longest period for which the data 
was available, to assess how many were not convicted 
of a drug-related crime and did not re-present to 
structured treatment/community DIP/prison DIP, or 
test positive for drugs at the custody suite. Clients 
who did not re-present to either the treatment or 
criminal justice datasets were deemed to be sustaining 
recovery and assumed to be committing no drug 
related offences33.
The 51,500 treatment leavers in 2005-06 were then 
matched with PNC convictions data to see if those 
who re-presented to treatment were responsible for 
more convictions34. This was indeed found to be the 
case with a mean of 7.2 convictions in the eight years 
prior to starting treatment for those who re-presented 
compared to 1.2 for those who did not re-present 
T26. EsTimaTEd REduCTion in oFFEnCEs FoR pEoplE susTaining long TERm 
RECovERy Who lEFT TREaTmEnT duRing sR10
Number of years drug taking career 
has potentially been shortened Lower estimate
Mid-point 
estimate Upper estimate
9 years 12.4m 16.6m 20.7m
8 years 11.1m 14.8m 18.4m
7 years 9.7m 12.9m 16.2m
6 years 8.3m 11.1m 13.9m
5 years 7.0m 9.3m 11.6m
4 years 5.6m 7.5m 9.3m
3 years 4.2m 5.6m 7.0m
2 years 2.8m 3.8m 4.7m
1 year 1.4m 1.9m 2.3m
0 years 0.0m 0.0m 0.0m
T24. EsTimaTEd REduCTion in oFFEnCEs FoR pEoplE susTaining long TERm 
RECovERy Who lEFT TREaTmEnT suCCEssFully in 2010-11 
Number of years drug taking career 
has potentially been shortened Lower estimate
Mid-point 
estimate Upper estimate
9 years 3.1m 4.1m 5.2m
8 years 2.8m 3.7m 4.6m
7 years 2.4m 3.2m 4.0m
6 years 2.1m 2.8m 3.5m
5 years 1.7m 2.3m 2.9m
4 years 1.4m 1.9m 2.3m
3 years 1.1m 1.4m 1.8m
2 years 0.7m 0.9m 1.1m
1 year 0.4m 0.5m 0.6m
0 years 0.0m 0.0m 0.0m
T25. EsTimaTEd REduCTion in oFFEnCEs pER pERson susTaining long TERm 
RECovERy on avERagE (2010-11)
DTORS offence type Lower estimate Mid-point estimate Upper estimate
Shoplifting 5.80 7.73 9.67
Theft of a vehicle 0.10 0.14 0.17
Theft from a vehicle 0.29 0.39 0.49
House burglary 0.09 0.12 0.15
Business burglary 0.26 0.35 0.44
Violent theft (robbery) 0.18 0.24 0.31
Bag snatch 0.13 0.18 0.22
Cheque or credit card fraud 0.32 0.43 0.53
Begging 0.96 1.28 1.60
Buying and selling stolen goods 8.46 11.28 14.10
Drug dealing 6.70 8.93 11.17
Prostitution 1.86 2.48 3.10
Other stealing 0.69 0.92 1.16
Total 26 34 43
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(Table 22).35 The period of eight years prior to 
treatment was used to closely match the drug taking 
‘career’ period prior to drug treatment (Figure 3). 
With 4.8 convictions being the mean number, 
this means that non re-presenters, i.e. those who 
are assumed to be sustaining recovery have a 
counterfactual which is 25.7% of the mean for clients 
in effective treatment (1.23/4.78). 
If we assume that the reduction in offences for those 
sustaining long term recovery was proportionate to the 
reduction in offences for those in effective treatment 
then we arrive at the following reductions (Table 23).
We can then apply the reductions to the 
counterfactual annual crime volume and using the 
mid-point estimate, we estimate that up to 4.1m 
crimes might be prevented over the next nine years as 
a consequence of the estimated 13,702 people who, 
having left treatment successfully in 2010-11, going 
on to sustain recovery in the long term (Table 24) 
(Assumption 2, Appendix B). 
We can also estimate that 34 offences may be 
prevented per person per year on average with a 
range from 26 to 43 (Table 25).
The number of offences which may be prevented due 
to investment over the SR10 period is estimated to 
be between of 0-16.6m offences (0-9 years) which 
may be prevented using the mid-point estimate, with 
a range from 0-12.4m using the lower estimate to 
0-20.7m using the upper estimate (Table 26). This 
assumes that investment remains the same over the 
SR10 period (Assumption 16, Appendix B).
Unit costs can then be applied to the number of 
offences where unit costs were available. We estimate 
that the total benefit in 2010-11 using the mid-point 
ranged from £0 for 0 sustaining recovery years, 
through to £700.6m for 9 sustaining recovery years 
(from clients who had left in 2009-10) with a range of 
£0-£525.5m to £0-£875.6m (Table 27). 
We estimate that there was potentially a £6,752 
benefit per person sustaining long term recovery on 
average in 2010-11 (from clients who had left in 2009-
10), with a range from £5,065 to £8,439 (Table 28). 
Using the mid-point, we estimate that all else being 
equal the value of the potential reduction in total 
offences for clients leaving treatment and sustaining 
long-term recovery due to investment over the 
spending review period will range from £0 for zero 
sustaining recovery years to £2.6bn for nine years, 
with a range of £0-£1.95bn to £0-£3.25bn (Table 29).
T29. EsTimaTEd valuE oF ThE REduCTion in ToTal oFFEnCEs FoR pEoplE 
susTaining long-TERm RECovERy Who lEFT TREaTmEnT in sR10 (2010-11 pRiCEs)
Number of years drug taking career 
has potentially been shortened Lower estimate
Mid-point 
estimate Upper estimate
9 years £1.95bn £2.60bn £3.25bn
8 years £1.76bn £2.35bn £2.94bn
7 years £1.56bn £2.09bn £2.61bn
6 years £1.36bn £1.82bn £2.27bn
5 years £1.16bn £1.54bn £1.93bn
4 years £0.94bn £1.26bn £1.57bn
3 years £0.72bn £0.96bn £1.20bn
2 years £0.49bn £0.65bn £0.81bn
1 year £0.25bn £0.33bn £0.41bn
0 years £0 £0 £0
T27. EsTimaTEd valuE oF REduCTion in oFFEnCEs FoR pEoplE susTaining long 
TERm RECovERy Who lEFT TREaTmEnT in 2010-11 (2010-11 pRiCEs)
Number of years drug taking career 
has potentially been shortened Lower estimate
Mid-point 
estimate Upper estimate
9 years £525.5m £700.6m £875.6m
8 years £475.0m £633.2m £791.4m
7 years £422.7m £563.5m £704.3m
6 years £368.5m £491.3m £614.0m
5 years £312.4m £416.4m £520.5m
4 years £254.3m £338.9m £423.6m
3 years £194.0m £258.6m £323.3m
2 years £131.6m £175.5m £219.3m
1 year £67.0m £89.3m £111.6m
0 years £0m £0m £0m
T28. EsTimaTEd valuE oF REduCTion in oFFEnCEs pER pERson susTaining long 
TERm RECovERy on avERagE (2010-11) (2010-11 pRiCEs)
DTORS offence type Lower estimate Mid-point estimate Upper estimate
Shoplifting £719 £959 £1,199
Theft of a vehicle £512 £683 £853
Theft from a vehicle £302 £403 £503
House burglary £353 £471 £589
Business burglary £1,219 £1,625 £2,031
Violent theft (robbery) £1,615 £2,153 £2,691
Bag snatch £100 £134 £167
Cheque or credit card fraud £244 £325 £406
Total £5,065 £6,752 £8,439
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conclusion
In its report on the previous drug strategy the National 
Audit Office recommended that “Departments 
responsible for delivering the Strategy should develop 
a framework for evaluating value for money”.36 
The aim of this report is to contribute to the drug 
treatment and recovery element of that framework. 
The NTA has worked closely with economists at the 
Home Office and the Department of Health to develop 
the first cross-government model which estimates 
the gross benefits from adult drug treatment and 
recovery in England.  It is hoped that this value for 
money model can help to raise hypotheses, provide 
theoretical frameworks and guide future work.
We estimate that drug treatment and recovery systems 
in England may have prevented approximately 4.9m 
crimes in 2010-11, with an estimated saving to 
society of £960m in costs to the public, businesses, 
the criminal justice system and National Health 
Service (NHS). We also estimate that approximately 
19.6m crimes may be prevented over the course of 
the Spending Review 2010 period (SR10) (2011-12 
to 2014-15), with an estimated saving to society of 
£3.6bn.
In addition we estimate that up to a further 4.1m 
offences may be prevented over a nine-year period 
(from 2011-12 to 2019-2020), because we estimate 
that 13,702 people who left treatment in 2010-11 will 
go on to sustain long term recovery, with an estimated 
value of £700m. We also estimate that continued 
investment in drug treatment at current levels over the 
SR10 period could lead to up to an estimated 54,000 
former clients sustaining long term recovery which 
may prevent up to 16.6m more offences over a nine-
year period with an estimated value of up to £2.6bn 
by 2023-24.
The model also helps us to estimate the potential 
impact of disinvestment in adult drug treatment. We 
estimate that, all else being equal, for every £1m 
taken out of the system there could be an increase of 
approximately 9,860 drug-related crimes per year at 
an estimated cost to society of over £1.8m.
It is important to remind the reader that many of the 
figures included in this report are estimates rather 
than observations and so these figures cannot be 
interpreted as direct, quantifiable measures of a causal 
effect of drug treatment and as such the findings are 
indicative and not definitive. We have tried to base our 
estimates on the best available evidence, but we are 
aware that there is not always as much evidence as we 
would like. These estimates can be improved over time 
as new evidence comes to light. 
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TERMINOLOGY DEFINITION
Benefits
This is a collective term to describe the positive gains made to an individual drug 
user, their community, businesses and public services from drug treatment and 
recovery. It includes cost savings and natural benefits.
Cost savings Reductions to the costs to individuals, businesses and public services brought about by investment in drug treatment.
Cash releasing savings Benefits which can be redeployed according to local or national priorities.
Cash (or nominal) terms A ‘cash’, or ‘nominal’, value refers to a value in a given year, or series of years, affected by inflation.
Cost This is the cost of structured drug treatment in the model. The model includes costs from the Adult Pooled Treatment Budget (PTB), local spending on drug treatment.
Counterfactual A hypothetical outcome in the absence of an intervention. In this case, an estimate of what would have happened to clients had they not entered drug treatment.
DIR Drug Intervention Records, owned by the Home Office, of drug-related offending and individuals engaged by specialist criminal justice drug teams.
Discounting
A technique for comparing cost and benefits that occur in different time periods. It is 
based on the economic principle that individuals prefer to receive goods and services 
now rather than later (‘time preference’). As a whole, it is suggested that society 
also prefers to receive benefits sooner and defer costs to future generations (‘social 
time preference’). In the VFM model, the social time preference rate is used as the 
standard real discount rate, as recommended by the Treasury37.  This rate comprises 
two components. First, the preference for consumption now with an unchanging level 
of consumption per capita over time (‘pure time preference’). Second, an additional 
element is added reflecting that if per capita consumption does grow over time, these 
circumstances imply future consumption will be plentiful relative to today and thus have 
lower marginal utility.
The social time preference rate is used to convert all costs and benefits to ‘present 
values’ to enable comparisons to be made. The Treasury recommended discount rate 
for both costs and cost savings is 3.5% up to year 30. The Department of Health use 
1.5% for natural benefits as we have done in the VFM model.  
Effective treatment
The NTA measure of effectiveness refers to the retention of clients for more than 
12 weeks, or leaving the treatment system before then in a care planned way.  Only 
clients who meet these criteria are included in the model.
National Drug Treatment  
Monitoring System (NDTMS)
Database owned by the NTA holding data on individual journeys through the 
treatment system.
Natural benefits
Intangible benefits, such as Quality Adjusted Life Years, which can be given a 
monetary value, but cannot be exchanged for money, for instance to reduce public 
spending. 
Non-Opioid and/or crack cocaine 
User (Non-OCU)
Clients not citing opiates, crack cocaine, or both, as any of their presenting 
substances.
Opioid and/or crack cocaine User 
(OCU) Clients citing opiates, crack cocaine, or both, as any of their presenting substances.
Police National Computer (PNC) Arrest, charge and conviction data on drug-related (and other) offenders.
Pooled Treatment Budget (PTB)  
A budget for drug treatment which is funded by the Department of Health and is 
allocated to local areas using an NTA funding formula based on the number of 
individuals effectively engaged in treatment. From April 2012, a proportion of the 
PTB will be allocated according to how successful a local area is in helping people to 
recover from their dependence.
QALY Quality Adjusted Life Years: the estimated additional quality and quantity of life due to an intervention.
Real terms
Adjusts cash values to remove the effects of price changes over time, relative to one 
chosen base period.  Converting into real terms makes cost-benefit comparisons 
fairer, as they reflect changes in outputs and outcomes rather than changes in 
inflation. 
Re-presentation Refers to a client who after exiting treatment in 2005-06 has re-presented to either drug treatment or the criminal justice system in the subsequent four year period.
Spending Review 10 (SR10) The period covering the four financial years from 2011-12 to 2014-15, for which HM Treasury has set public sector budgets.
Structured treatment Treatment where the client has a care plan.
Successful completions
Successful completions were made up of two categorioes: treatment completed - 
drug free; treatment completed - occasional user. 
Treatment completed – Drug free Data item definition: The client no longer requires 
structured drug treatment interventions and is judged by the clinician not to be using 
heroin (or any other opioids) or crack cocaine or any other illicit drug.
Treatment Completed - Occasional user (not heroin and crack) Data item definition: 
The client no longer requires structured drug treatment interventions and is judged 
by the clinician not to be using heroin (or any other opioids) or crack cocaine.  There 
is evidence of use of other illicit drug use but this is not judged to be problematic or to 
require treatment.
appendix a: glossary
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ASSUMPTIONS NOTES
The mean drug taking ‘career’ 
in the absence of treatment is 20 
years for all clients (the drug tak-
ing ‘career’ counterfactual). 
While there may be different average ‘career’ durations for different drugs and 
different combinations of drugs, we assume the 20 year counterfactual applies to 
all clients as a proxy. The 20 year counterfactual is an average figure and so might 
include some people who have taken drugs throughout their lives and others who 
have used drugs only once. Also, this will include some people who have been in 
treatment at some point in their lives. 
There is also a possibility that drug treatment extends the ‘career’ for some and 
reduces it for others38. This would have implications on ‘career’ length and the 
number of sustaining recovery years to which a benefit can be ascribed. Our analysis 
of treatment leavers in 2005-06 suggests that 27% sustain recovery, but it’s not clear 
from the analysis whether the other 73% never recover.
The 20 year counterfactual ‘career’ is a very difficult figure to improve on due to the 
limited evidence and lack of a control trial. We have shared this with academics and 
government departments and this has been unanimously accepted as a reasonable 
estimate.
References
Degenhardt, L., Mattick, R., and Gibson, A. (2009) Pharmacotherapies for the 
treatment of opioid dependence: Efficacy, Cost-Effectiveness, and Implementation 
Guidelines. Mattick, R., Ali, R., and Lintzeris, N. Eds. New York: Informa Healthcare 
USA.
Best, D., Day, E. and Morgan, B. (2006). Average Length of an Opiate Using ‘Career’. 
London: NTA.
Expert group opinion. (Meeting in May 2010)
Counterfactual costs are spread 
equally over the 20 year coun-
terfactual drug taking ‘career’ 
period.
All re-presentation matches 
based on attributers in the 
NDTMS and CJS datasets relate 
to an individual.
False positive matching in re-presentation calculations would affect the sustaining 
recovery rate. The National Drug Evidence Centre at the University of Manchester 
looked into false positive matching of criminal justice and treatment datasets and 
found that very few matches were made for different people, giving an undercount of 
3%. Without doing a case audit, we do not know what the incidence of false negatives 
might be, but for the purposes of the report, we assume that it is the same incidence 
as false positives and so they both cancel each other out. 
References
Millar, T. (2011, pers. comm., 5 April).
No sustaining recovery benefits 
attributed to clients who re-
present to drug treatment or the 
criminal justice system.
Former clients who re-present to drug treatment or the criminal justice system are 
likely to accrue sustaining recovery benefits before they relapse, however because we 
don’t know when they relapse it is not possible to estimate what the benefits might 
be.
The outcome improvements are 
due to drug treatment and not 
other confounding variables, i.e. 
there is no deadweight.
It would be both unethical and illegal to withhold NICE endorsed treatment for 
individuals with a treatment need. As a result it is not possible to conduct a 
randomised control trial to verify the degree to which drug treatment impacted on 
outcomes rather than other factors. The absence of a control group who sought 
treatment but were refused it means that it is not possible to ascribe with a high 
degree of confidence any observed changes in outcomes to structured treatment 
specifically. However, evidence shows that as new people engage with treatment 
and become abstinent they experience positive benefits, which may not be wholly 
attributed to treatment, but where treatment is likely to play a critical role.
The offending committed by drug 
treatment clients is drug-related.
The crimes that have been included are trigger offences known to be strongly 
associated with drug use.
References
See: http://www.homeoffice.gov.uk/about-us/corporate-publications-strategy/home-
office-circulars/circulars-2004/042-2004/621142?view=Binary
appendix b: Key assumptions
Sustaining long-term recovery
Used in reference to clients who were in effective treatment, have exited treatment 
successfully and do not re-present to treatment services, have contact with the 
criminal justice system, or die up to ten years after they exit treatment.
Value for Money
Value for Money (VFM) can be absolute or relative. If an organisation obtains a net 
benefit from the investment they make it can be regarded as VFM. If they improve 
the benefits in relation to the costs then they have increased VFM. The goal is to 
maximise VFM by achieving the maximum benefits in relation to costs. Achieving 
value for money may be described in terms of economy, efficiency, effectiveness and 
equity. 
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The change in convictions is 
representative of the change we 
would see in offences and that 
this relationship remains the 
same after conviction.
That the DTORS cohort is repre-
sentative of the whole treatment 
population.
We have assumed that the DTORS cohort is representative of the whole treatment 
population as DTORS stated that its “...sample of 1,796 adults...were broadly 
representative of the population of Tier 3 and Tier 4 treatment-seekers in England.” 
See: http://www.dtors.org.uk/reports/DTORS_Key_Summary.pdf (page ii)
Benefits are only ascribed (a) to 
clients in effective treatment, i.e. 
the retention of clients in treat-
ment for more than 12 weeks, 
or leaving the treatment system 
before then in a care planned way 
and (b) clients who have had a 
successful completion and go on 
to sustain long term recovery.
While there might be significant benefits for those individuals that do not reach the 12 
week point or leave in an unplanned way before then, they have not been included in 
the analysis. 
There are also likely to be treatment benefits for clients who do not leave treatment 
successfully but go on to sustain long term recovery as a result of treatment, as 
a proportion of those in treatment simply walk away once it has met their clinical 
needs without engaging with the formal administrative discharge process required 
by NDTMS. However, we do not count them to avoid the risk of overestimating the 
potential benefits of treatment. See: http://www.nta.nhs.uk/uploads/outcomes_of_
drug_users_leaving_treatment2010.pdf
For all these reasons we may have underestimated the benefits of treatment.
Drug related crime rates remain 
at 2010-11 levels over the SR10 
period.
That the number of people en-
gaged in effective treatment will 
remain the same each year of the 
SR10 period.
The estimated potential benefits 
of drug treatment remain the 
same each year of SR10.
That the mean time in effective 
treatment remains the same 
each year of SR10.
That the disinvestment in the dis-
investment scenario falls equally 
across all treatment types. 
The in treatment mortality rate 
(0.503%) is the same for former 
clients sustaining long term 
recovery. 
Investment over the SR10 period 
will remain the same.
appendix c: a taxonomy of drug-related harms
BEARER OF 
COSTS/HARMS
ExAMPLES OF 
COSTS COMMENT
DRUG USERS
Premature 
death
Systematic reviews on the mortality of opiate users estimate annual death rates of 
about 1%, which is more than 10 times that of the general population39. The rate 
of 0.503% has been applied in the VFM model as the observed mortality rate taken 
based on NDTMS data.
Loss of quality 
of life: mental 
and physical 
health.
Prolonged use of cocaine can lead to mental health problems, with different routes of 
administration associated with different negative consequences:  crack cocaine users 
have high levels of anxiety, depression and paranoid ideation. Other symptoms, such 
as aggression and violence, are also associated more with crack cocaine than with 
cocaine powder40.  
Along with poor mortality and its relationship with blood borne viruses, heroin 
injection is associated with poor psychosocial functioning41.
Prolonged cannabis use has been linked to psychosis, and studies have shown a link 
between use of marijuana and depression42.  
The quality of life of drugs before, during and after treatment are reflected in the VFM 
model as Quality Adjusted Life Years (QALYs) and will be published in a second report 
later in the year.
Contract-
ing HIV/other 
diseases 
Injecting drug users are vulnerable to a wide range of infections, including those 
which are transmittable. According to the Health Protection Agency, around a half of 
injecting drug users have been infected with hepatitis C and about one in 100 with HIV. 
Around one in six injectors have had hepatitis B (2011)43. 
Impact on 
educational 
achievement, 
training oppor-
tunities
People not in employment, education or training at age 16-18 are more likely to have 
had long-term health problems, mental illness and be involved in drug abuse.
Taking drugs can negatively impact on the educational attainment and motivation of 
young people, thereby impeding their future employability44.  The monetary value of 
this impact is unknown and therefore has not been included in the VFM model.
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Excess unem-
ployment and 
loss of lifetime 
earnings
Systematic reviews on the mortality of opiate users estimate annual death rates 
of about 1%, which is more than 10 times that of the general population. The rate 
of 0.503% has been applied in the VFM model as the observed mortality rate taken 
based on NDTMS data.
Increased 
vulnerability 
A sizable proportion of OCUs tend to be vulnerable with multiple support needs, such 
as homelessness, sex working and mental health problems.
Homelessness
There are multiple harms associated with homelessness. Between a third and 
two-thirds of rough sleepers have a drug addiction45 46. Homeless clients are 47 
times more likely to be the victim of theft and 13 times more likely to be the victim of 
violence than the general population47. Also, homeless people are nearly five times 
more likely to die younger than their equivalent age group of the general population48. 
Treatment Outcomes Profile (TOP)49 data shows that the housing situation for drug 
treatment clients improves while clients are engaged in effective treatment (e.g. 
64.2% of clients recorded as No Fixed Abode (NFA) at the start of treatment were no 
longer NFA at the TOP review stage roughly 6 months later and 71.4% who had an exit 
TOP were no longer NFA.)
Moving a homeless client into stable accommodation plays an important part in 
reducing harms, beyond supporting their engagement in treatment50. However, owing 
to lack of quantitative data, further work needs to be done before these benefits can 
be factored into the VFM model. 
Sex working
While the relationship between sex and srug markets is not demonstrably causal, 
women involved in street prostitution typically spend over 75% of their income on 
drugs, drug addiction is often reported as a reason for entry into sex working51. 
Unfortunately it is unclear from the treatment data how many service users are sex 
working and therefore it is not currently possible to measure the likely benefits from 
being in treatment and recovering from addiction. 
Mental health
Many studies have highlighted a link between mental health problems and drug 
addiction, e.g. the DTORS study found that many drug users in treatment had 
experience of mental health services, with 37% of the cohort having previously been 
referred to a psychiatrist of other mental health professional52. Prolonged periods 
of abstinence are known to generally reduce psychiatric disorders and improve 
mental well-being53. Improvements in mental well-being have been included in the 
model as part of the QALY measure. Reductions in access to mental health services 
and individual benefits of reductions specific to psychiatric episodes have not been 
included owing to the lack of data. 
FAMILIES/
CARERS
Impact on  
foetuses/
babies
Cocaine use during pregnancy is linked to, miscarriage, intrauterine growth 
retardation, premature delivery and acute distress, among others. Newborns can be 
born addicted to drugs such as heroin and cocaine. They can enter the withdrawal 
stages from cocaine within 48 hours of birth54, as well as suffer poor nutritional 
health, possible heart disease risk and emotional developmental impairment.
Impaired 
parenting
Parental drug and alcohol use is often mentioned as an issue for children who are 
counselled by ChildLine55. 
NDTMS data showed that in 2008-09, 3.5% of OCUs and 1.6% of non-OCUs in 
treatment had a child being looked after by a local authority, compared to 0.58% in the 
general population56. It is felt that the actual number in contact with social care for 
this group of drug users may be higher still. 
It is unclear how many children were in contact with social care as a direct result 
of parental problem drug use We are hoping to do further work , possibly by 
anonymously matching local authority children and social care data to NDTMS data, 
to see whether the demands placed on children and social care budgets fall when 
parents are engaged in effective treatment. 
Domestic 
violence
There is a strong, albeit not causal, link between drug addiction and domestic 
violence. The British Crime Survey revealed that 12% of domestic violence 
perpetrators were affected by drugs when they committed acts of physical violence57. 
In a study of inner London drug treatment agencies in 2000, 30% of women reported 
physical violence from their current partner58. Furthermore, in one study of service 
users of domestic violence agencies, over half of respondents (51%) claimed that 
either themselves or their partners had used drugs, alcohol and/or prescribed 
medication in ‘problematic ways’ in the last 5 years; and almost two-thirds began 
their problematic use following their experience of domestic violence59.
These figures are estimated to be higher due to the fear and difficulty in disclosing 
experiences of abuse. Given the chronic underreporting of domestic violence and 
the fact that reducing substance use may not lead to a reduction in the occurrences 
of domestic violence, it is not possible to estimate the benefits of drug treatment in 
alleviating the problem. 
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Victim of crime
Adult family members and/or carers of drug users can experience the theft of money 
and personal property committed by their drug dependent relative60. While it is 
unlikely that the majority of these crimes would be reported to the police or would 
be included in self-reported crimes, we have not included these costs in the crime 
component of the VFM model to avoid any possibility of double-counting with the 
other drug related crime data we have included.
Reduced 
performance at 
school
This cost is likely to be significant, but is not reflected in the model because the VFM 
model only considers the benefits and costs of adult drug treatment61. 
Transmission of 
infections
This cost is likely to be significant, but is not reflected in the model owing to lack of 
data.
Intergenera-
tional impact of 
drug use
This cost is likely to be significant, but is not reflected in the model owing to lack of 
data. 
Financial 
problems
Families are often a major source of financial support for drug users. Moreover, adult 
family members/ carers may need to put aside their usual activities to help their 
relative or because of stress-related problems. This could result in lost employment 
opportunities or reduced productivity. 
These costs are estimated to amount to approx. £6,000 annually62. This saving has not 
been included in the model because we do not know the impact drug treatment has 
on this problem.  
Concern/worry 
for users
There is currently no measure on the effects of worrying for drug dependent loved 
ones.
Increased 
health service 
needs for family 
members
The UKDPC estimates that the additional healthcare costs to families from living 
with family members with a drug treatment need is approximately £450 per family 
member per year63.
Caring for drug 
users or drug 
users’ depend-
ants
Family members and carers often provide informal care which might otherwise be 
picked up by the NHS or local authority (LA), e.g. nursing and home care, over and 
above the time that would be committed to taking care of any other family member. 
Family members taking care of drug using OCU relatives is estimated to save the 
NHS and LA approx. £4,000 per annum per person64. 
Victims of drug 
driving These harms are not reflected in the VFM model owing to lack of data.
Drug-related 
violence
The violence associated with drug markets is significant and well-documented. The 
violence can vary from gang-related violence to robbery offences committed to fund 
addiction. The benefits of reducing robbery offences are included in the VFM model. 
OTHER 
INDIVIDUALS 
DIRECTLY 
AFFECTED
Drug-related 
crime
The cost to society in England and Wales of drug related problem Class A drug use 
has been estimated by the Home Office to be approximately £13.9bn a year65 66. The 
types of offences vary from the possession and supply of illegal drugs to acquisitive 
crimes committed to fund addiction. There are a wide range of studies which suggest 
that drug treatment reduces drug-related crime. These costs and benefits have been 
included in the VFM model and are outlined in this report. 
Transmissions 
of infections 
from drug  
users to others
This cost is likely to be significant, but is not reflected in the VFM model owing to lack 
of data.
WIDER 
COMMUNITY 
EFFECTS
Drug litter
Litter related to drug use can cover a range of materials, e.g. syringes, foils, spoons, 
plastic bottles. It could also include other detritus such as bodily waste often found in 
areas that have been used for drug use. 
The health risks to the public from drug litter are often thought to be small – there 
are still no recorded incidents of a member of the public contracting a blood-borne 
disease from a discarded needle or syringe67. 
There are costs to local areas in disposing of drug litter in a safe and timely manner. 
However, there are no available national figures and so these have not been included 
in the VFM model.
Fear of crime This cost is likely to be significant, but is not reflected in the VFM model owing to lack of data.
Reduced prop-
erty values near 
drug markets
This cost is likely to be significant, but is not reflected in the VFM model owing to lack 
of data.
INDUSTRY Sickness ab-sence
This cost is likely to be significant, but is not reflected in the VFM model owing to lack 
of data.
Theft in the 
workplace
This cost is likely to be significant, but is not reflected in the VFM model owing to lack 
of data.
Security 
expenditure to 
prevent drug-
related crime
This cost is reflected in the drug related crime estimates.
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Productivity 
losses
This cost is likely to be significant, but is not included in the VFM model owing to a 
lack of data.
Impact of  
illicit markets 
on legitimate 
markets
Business will be less likely to invest in areas with high concentrations of drug-related 
crime and visible drug markets. This cost is likely to be significant, but is not reflected 
in the VFM model owing to lack of data.
PUBLIC 
SECTOR
Health care 
expenditure
These are NHS costs incurred by drug users because of their drug use. Some of the 
drug-related health risks have been mentioned in the harms to drug users section. 
Criminal justice 
expenditure
The largest component of the criminal justice costs of drug-related crime is made up 
of the cost of the police response to crime, followed by costs of custody and enforcing 
community sentences. These costs have been included in the VFM model. 
Social services Not currently included in the VFM model due to lack of data.
Social security 
benefits
Research has suggested that 1 in 15 of all Department of Work and Pensions benefit 
claimants are OCUs68, or put another way 80.3% of OCUs are estimated to be benefit 
claimants at significant cost to the Exchequer.  
appendix d: matching dtors offence categories with offences in legislation
TERMINOLOGY DEFINITION
SHOPLIFTING 4600 Theft Act 1968 Sec.1 Stealing from shops and stalls (shoplifting).
THEFT OF A 
VEHICLE 13001
Theft Act 1968 S.12 (1) as amended by Criminal Justice Act 1988 S.37 Unauthorised 
taking of a motor vehicle.
13002 Theft Act 1968 S.12 (1) as amended by CJA 1988 S.37. Unauthorised taking of conveyance other than a motor vehicle or pedal cycle. 
13003 Theft Act 1968 S.12 (1) as amended by Criminal Justice Act 1988 S.37 Being carried knowing vehicle to have been taken.
13101
Theft Act 1968 S.12A as added by the Aggravated Vehicle Taking Act 1992 S.2 – 
Aggravated vehicle taking where the only aggravating factor is criminal damage of 
£5000 or under.
13718 Theft Act 1968 Sec.12 (5) or Bylaw. Take or ride a pedal cycle without consent etc.
3702 Theft Act 1968 S.12A - aggravated taking where the vehicle was driven dangerously on a road or other public place.
4400 Theft Act 1968 Sec.1 Theft of a pedal cycle.
4801 Theft Act 1968 Sec.1 Theft of motor vehicle.
4912 Theft Act 1968 Sec.1 Stealing conveyance other than motor vehicle or cycle.
THEFT FROM 
A VEHICLE 4510 Theft Act 1968 Sec.1 Stealing from motor vehicles.
4511 Theft Act 1968 Sec.1 Stealing from other vehicles.
HOUSE 
BURGLARY 2801
Theft Act 1968 Sec.9 Burglary in a dwelling with intent to commit or commits an 
offence triable only on indictment.
2802 Theft Act 1968 Sec.9 Burglary in a dwelling with violence or the threat of violence.
2803 Theft Act 1968 Sec.9 Other burglary in a dwelling.
2900 Theft Act 1968 Sec.10 Aggravated burglary in a dwelling (including attempts).
BUSINESS 
BURGLARY 3001
Theft Act 1968 Sec.9 Burglary in a building other than a dwelling with intent to 
commit or the commission of an offence.
3002 Theft Act 1968 Sec.9 Other burglary in a building other than a dwelling.
3100 Theft Act 1968 Sec.10 Aggravated burglary in a building other than a dwelling (including attempts ).
VIOLENT 
THEFT 
(ROBBERY)
3401 Theft Act 1968 Sec.8 Robbery.
3402 Theft Act 1968 Sec.8 Assault with intent to rob.
BAG SNATCH 3900 Theft Act 1968 Sec.1 Stealing from the person of another.
CHEQUE OR 
CREDIT CARD 
FRAUD
5301 Theft Act 1968 Sec.15 Obtaining property by deception.
5331 Theft Act 1968 s.15a as added by Theft (Amendment) Act 1996 s.1 - obtaining a money transfer by deception.
5340 Fraud Act 2006 s.2. Fraud by deception.
5341 Fraud Act 2006 s.3. Fraud by failing to disclose information.
5342 Fraud Act 2006 s.4. Fraud by abuse of position.
5343 Possession etc. of articles for use in frauds; Fraud Act 2006 S.6
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BEGGING 10431 Vagrancy Act 1824 Sec.4 and 5. Resisting or obstructing constables in execution of duty.
18200 Begging - Vagrancy Act 1824.
18501 Vagrancy Act 1824 Sec.4 Being on enclosed premises for an unlawful purpose.
BUYING AND 
SELLING 
STOLEN 
GOODS
5401 Theft Act 1968 Sec.22 Receiving stolen goods.
5402 Theft Act 1968 Sec.22 Undertaking or assisting in the retention, removal disposal or realisation of stolen goods or arranging to do so.
DRUG 
DEALING 9211
Production or being concerned in the production of class A drug Heroin. Misuse of 
Drugs Act 1971 Sec .4 (2).
9210 Supplying offering to supply or being concerned in class A controlled drug Cocaine. Misuse of Drugs Act 1971 sec 4 (3). 
9231 Supplying offering to supply or being concerned in class A controlled drug Heroin. Misuse of Drugs Act 1971 sec 4 (3).
9233 Supplying offering to supply or being concerned in class A controlled drug MDMA. Misuse of Drugs Act 1971 sec 4 (3).
9234 Supplying or offering to supply a controlled drug Class A 'Crack'. Misuse of drugs Act 1971 Sec 4(3).
9235 Misuse of Drugs Act 1971 - Supplying or offering to supply a controlled Class A Drug - Methadone.
9239 Supplying offering to supply or being concerned in other class A controlled drug. Misuse of Drugs Act 1971 sec 4 ( 3 )
9254 Having possession of a controlled drug with intent to supply. Class A ' Crack'. Misuse of drugs Act 1971 Sec 4(2).
9255 Misuse of Drugs Act 1971 - Sec 5 (2) Having possession of a Controlled Drug with intention to supply - Class A Methadone. Misuse of drugs Act 1971 Sec 4(2).
9259 Possession with intent to supply other class A controlled drug. Misuse of Drugs Act 1971 Sec 5 (3).
9295 Producing controlled drug - Class A;  Misuse of Drugs Act 1971 S.4(2)(a)
9315 Misuse of Drugs Act 1971 - Sec 8 - Permitting premises to be used for unlawful purposes - Class A drug – Methadone
PROSTITUTION 16604 Street Offences Act 1959 Sec.1 Common prostitute loitering or soliciting for the purpose of prostitution.
OTHER 
STEALING 3300 Theft Act 1968 Sec.25 Going equipped for stealing etc.
4000 Theft Act 1968 Sec.1 Stealing in a dwelling other than from automatic machines and meters.
4100 Theft Act 1968 Sec.1 Stealing by an employee.
4200 Post Office Act 1953 Sec.53 Unlawfully taking away or opening mail bag.
4700 Theft Act 1968 Sec.1 Stealing from automatic machines and meters.
4910 Theft Act 1968 Sec.1 Stealing not classified elsewhere.
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appendix e: sustaining long term recovery data
T30. CalCulaTing ThE susTaining long TERm RECovERy CohoRT FRom numBERs in EFFECTivE TREaTmEnT in 2010-11 (assuming ThaT dRug 
Taking ‘CaREERs’ havE BEEn shoRTEnEd By 9 yEaRs) 
2010-11 cohort 2010-11 2011-12 2012-13 2013-14 2014-15 2015-16 2016-17 2017-18 2018-19 2019-20
Sustaining long term recovery flow 13,702 0 0 0 0 0 0 0 0 0
Sustaining long term recovery stock 0 13,702 13,633 13,565 13,496 13,429 13,361 13,294 13,227 13,161
Sustaining long term recovery stock deaths 0 69 69 68 68 68 67 67 66 66
Sustaining long term recovery stock 
(mortality adjusted) 0 13,633 13,565 13,496 13,429 13,361 13,294 13,227 13,161 13,094
0 0.00503 0.00503 0.00503 0.00503 0.00503 0.00503 0.00503 0.00503 0.00503
T31. CalCulaTing ThE susTaining long TERm RECovERy CohoRT FRom numBERs in EFFECTivE TREaTmEnT in 2010-11 
(WiTh ThE numBERs oF yEaRs By WhiCh ThE dRug Taking ‘CaREER’ has poTEnTially BEEn shoRTEnEd By Ranging 
FRom 0 To 9 yEaRs)
Number of years 
drug taking ‘career’ 
has potentially been 
shortened 
2010-11 2011-12 2012-13 2013-14 2014-15 2015-16 2016-17 2017-18 2018-19 2019-20
9 years 0 13,633 13,565 13,496 13,429 13,361 13,294 13,227 13,161 13,094
8 years 0 13,633 13,565 13,496 13,429 13,361 13,294 13,227 13,161 0
7 years 0 13,633 13,565 13,496 13,429 13,361 13,294 13,227 0 0
6 years 0 13,633 13,565 13,496 13,429 13,361 13,294 0 0 0
5 years 0 13,633 13,565 13,496 13,429 13,361 0 0 0 0
4 years 0 13,633 13,565 13,496 13,429 0 0 0 0 0
3 years 0 13,633 13,565 13,496 0 0 0 0 0 0
2 years 0 13,633 13,565 0 0 0 0 0 0 0
1 year 0 13,633 0 0 0 0 0 0 0 0
0 years 0 0 0 0 0 0 0 0 0 0
T32. CalCulaTing ThE susTaining long TERm RECovERy CohoRT FRom numBERs in EFFECTivE TREaTmEnT in 2010-11 (WiTh ThE numBERs oF yEaRs By 
WhiCh ThE dRug Taking ‘CaREER’ has poTEnTially BEEn shoRTEnEd By Ranging FRom 0 To 9 yEaRs)
Number of years 
drug taking ‘career’ 
has potentially been 
shortened 
2011-12 2012-13 2013-14 2014-15 2015-16 2016-17 2017-18 2018-19 2019-20 2020-21 2021-22 2022-23 2023-24
9 years 0 13,633 27,198 40,694 54,123 53,851 53,580 53,311 53,043 52,776 39,482 26,255 13,094
8 years 0 13,624 27,180 40,668 54,088 53,807 53,528 53,250 52,974 39,682 26,388 13,161 0
7 years 0 13,624 27,171 40,641 54,034 53,728 53,422 53,119 39,726 26,408 13,166 0 0
6 years 0 13,624 27,171 40,641 54,034 53,728 53,422 39,952 26,559 13,242 0 0 0
5 years 0 13,624 27,171 40,641 54,034 53,728 40,181 26,711 13,317 0 0 0 0
4 years 0 13,624 27,171 40,641 54,034 40,410 26,863 13,393 0 0 0 0 0
3 years 0 13,624 27,171 40,641 40,641 27,017 13,470 0 0 0 0 0 0
2 years 0 13,624 27,171 27,171 27,171 13,547 0 0 0 0 0 0 0
1 year 0 13,624 13,624 13,624 13,624 0 0  0 0 0 0 0
0 years 0 0 0 0 0 0 0 0 0 0 0 0 0
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